High Interval Versus Moderate Intensity Continuous Training on Soluble st2 Biomarkers in Chronic Heart Failure
NCT ID: NCT06647667
Last Updated: 2024-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-09-15
2023-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of HIIT, MICT in Patients With Myocardial Infarction
NCT04863677
High Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection Fraction
NCT02916225
Effectiveness of Low -Versus High -Volume High -Intensity Interval Training in Patients With Chronic Heart Failure
NCT07325942
Impact of Interval Training on Sympathetic Hyperactivity and Vascular Function
NCT04248894
Effect of Aquatic High Intensity Resistive Training on Patients With Chronic Heart Failure
NCT06297707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
2. Patients will receive moderate intensity continuous training (MICT)
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
high intensity interval training
HIITS
Frequency: HIIT will be in 2 supervised sessions per week for 12 weeks on the treadmill.
session duration from 30-40 min including the waming up and cooling down Intensity: HIIT included 4 minute intervals aiming 60-85% of heart rate reserve
group B
moderate intensity continuous training
MICT
Frequency: Moderate continuous training is scheduled 2 times per week for 12 weeks.
Intensity: exercise had been applied on the treadmill with 40%-59% of heart rate reserve) session duration from 30-40 min including the warming up and cooling down
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIITS
Frequency: HIIT will be in 2 supervised sessions per week for 12 weeks on the treadmill.
session duration from 30-40 min including the waming up and cooling down Intensity: HIIT included 4 minute intervals aiming 60-85% of heart rate reserve
MICT
Frequency: Moderate continuous training is scheduled 2 times per week for 12 weeks.
Intensity: exercise had been applied on the treadmill with 40%-59% of heart rate reserve) session duration from 30-40 min including the warming up and cooling down
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with chronic heart failure (New York heart association class I\& II) with systolic left ventricular dysfunction.
* Their left ventricular ejection fraction (LVEF) \<40%.
* Medical treatment was optimized at least three months prior to study entry.
* All patients didn't participate in any rehabilitation programs prior to the study.
Exclusion Criteria
1. Signs of acute heart failure, unstable angina or severe arrhythmia three months prior to enrolment in the study.
2. Pacemakers.
3. Chronic obstructive pulmonary disease.
4. Other disorders counteracting exercise testing conditions that limit lower limb mobility (for example, burns, fractures)
5. Pre-existing neuromuscular diseases (for example Myasthenia Gravis).
50 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Reda Ali
PhD candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donia M Elmasry, Doctorate
Role: STUDY_DIRECTOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of physical therapy Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.